Lawrence Steinman

Lawrence Steinman has an estimated net worth of $2.82 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Pasithea Therapeutics Corp., 180 Life Sciences Corp., Atreca, Inc., and BioAtla, Inc..

2022 was Lawrence Steinman's most active year for acquiring shares with 11 total transactions. Lawrence Steinman's most active month to acquire stocks was the month of May. 2005 was Lawrence Steinman's most active year for disposing of shares, totalling 4 transactions. Lawrence Steinman's most active month to dispose stocks was the month of February. 2004 saw Lawrence Steinman paying a total of $690,120.00 for 12,000 shares, this is the most they've acquired in one year. In 2005 Lawrence Steinman cashed out on 4,000 shares for a total of $164,406.02, their largest year based on trade value.